A detailed history of Insight 2811, Inc. transactions in Danaher Corp stock. As of the latest transaction made, Insight 2811, Inc. holds 1,829 shares of DHR stock, worth $423,011. This represents 0.26% of its overall portfolio holdings.

Number of Shares
1,829
Previous 2,028 9.81%
Holding current value
$423,011
Previous $506,000 0.4%
% of portfolio
0.26%
Previous 0.26%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$239.25 - $280.76 $47,610 - $55,871
-199 Reduced 9.81%
1,829 $508,000
Q2 2024

Aug 06, 2024

BUY
$235.51 - $267.98 $235 - $267
1 Added 0.05%
2,028 $506,000
Q1 2024

May 06, 2024

SELL
$224.58 - $256.19 $44,916 - $51,238
-200 Reduced 8.98%
2,027 $506,000
Q4 2023

Feb 12, 2024

SELL
$185.1 - $233.13 $2,406 - $3,030
-13 Reduced 0.58%
2,227 $515,000
Q3 2023

Nov 14, 2023

BUY
$233.08 - $265.59 $5,127 - $5,842
22 Added 0.99%
2,240 $555,000
Q2 2023

Aug 04, 2023

SELL
$224.99 - $256.14 $125,094 - $142,413
-556 Reduced 20.04%
2,218 $532,000
Q1 2023

May 11, 2023

SELL
$239.75 - $277.0 $122,512 - $141,547
-511 Reduced 15.56%
2,774 $699,000
Q4 2022

Feb 07, 2023

BUY
$241.42 - $282.29 $4,586 - $5,363
19 Added 0.58%
3,285 $872,000
Q3 2022

Nov 14, 2022

BUY
$247.06 - $1507.4 $593,191 - $3.62 Million
2,401 Added 277.57%
3,266 $844,000
Q2 2022

Aug 09, 2022

BUY
$237.11 - $299.66 $10,432 - $13,185
44 Added 5.36%
865 $219,000
Q1 2022

May 06, 2022

SELL
$257.27 - $315.76 $5,402 - $6,630
-21 Reduced 2.49%
821 $241,000
Q4 2021

Feb 01, 2022

BUY
$292.08 - $329.01 $245,931 - $277,026
842 New
842 $277,000
Q3 2021

Nov 04, 2021

SELL
$272.21 - $332.43 $230,561 - $281,568
-847 Closed
0 $0
Q2 2021

Aug 04, 2021

BUY
$225.08 - $271.69 $190,642 - $230,121
847 New
847 $227,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $168B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Insight 2811, Inc. Portfolio

Follow Insight 2811, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Insight 2811, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Insight 2811, Inc. with notifications on news.